There is an urgent need for of reliable and sensitive biomarkers for early diagnosis and identification of patients at risk to develop neurological complications after brain imjury as a pre-requisite to challenge neuroprotective therapies. Using inhouse imaging and signal-based algorithms we show that early BBB dysfunction and specific EEG features, respectively, have the potential to serve as predictors for postinjury epilepsy.


Imaging blood-brain barrier dysfunction in football players.

Imaging blood-brain barrier dysfunction as a biomarker for epileptogenesis.

Angiographic evidence of proliferative retinopathy predicts neuropsychiatric morbidity in diabetic patients.

Electrocorticographic Dynamics as a Novel Biomarker in Five Models of Epileptogenesis.